AVR Stock Summary and Trading Ideas (Anteris Technologies Global Corp. | NASDAQ:AVR)

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Anteris Technologies Global Corp. trades on the NASDAQ stock market under the symbol AVR.

As of April 4, 2025, AVR stock price declined to $3.22 with 392,008 million shares trading.

AVR has a beta of 1.38, meaning it tends to be more sensitive to market movements. AVR has a correlation of 0.07 to the broad based SPY ETF.

AVR has a market cap of $115.73 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that AVR belongs to (by Net Assets): IWN, IWO, IWC, RSSL, UWM.

AVR support price is $3.03 and resistance is $3.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVR shares will trade within this expected range on the day.